Home » New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

This post was originally published on this site.

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.